The Robert E. Spiller Veterans Center in Bowling Green is nearing completion, and veterans are invited to help create its ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

OXB announces that its proprietary lentiviral vector manufacturing technology will be used in Boehringer Ingelheim’s newly initiated LENTICLAIR ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Meghan Markle recently debuted her new lifestyle brand, As Ever, but eagle-eyed viewers have noticed some design parallels in ...

The strata retail market remained muted in the second half of 2024, with a slight decline of 1.3% in total sales value to S$214.8 million from S$217.5 million i ...

According to a Cushman and Wakefield report, for the whole year 2024, Ho Chi Minh City had 117,500 sqm of new supply from five Grade A buildings, three of which ...